Genmab
GMAB
GMAB
233 hedge funds and large institutions have $1.67B invested in Genmab in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 96 increasing their positions, 56 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% more capital invested
Capital invested by funds: $1.59B → $1.67B (+$89.5M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
22% less call options, than puts
Call options by funds: $1.61M | Put options by funds: $2.07M
Holders
233
Holding in Top 10
2
Calls
$1.61M
Puts
$2.07M
Top Buyers
| 1 | +$107M | |
| 2 | +$46.8M | |
| 3 | +$16.1M | |
| 4 |
Renaissance Technologies
New York
|
+$11.8M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$8.96M |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$12.3M | |
| 3 | -$6.08M | |
| 4 |
Two Sigma Investments
New York
|
-$5.13M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$4.32M |